225 related articles for article (PubMed ID: 16641457)
21. In vitro activities of dermaseptins K4S4 and K4K20S4 against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa planktonic growth and biofilm formation.
Zaïri A; Ferrières L; Latour-Lambert P; Beloin C; Tangy F; Ghigo JM; Hani K
Antimicrob Agents Chemother; 2014; 58(4):2221-8. PubMed ID: 24492362
[TBL] [Abstract][Full Text] [Related]
22. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections.
Ahearn DG; Grace DT; Jennings MJ; Borazjani RN; Boles KJ; Rose LJ; Simmons RB; Ahanotu EN
Curr Microbiol; 2000 Aug; 41(2):120-5. PubMed ID: 10856378
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial nanocomposite coatings for rapid intervention against catheter-associated urinary tract infections.
Patra D; Ghosh S; Mukherjee S; Acharya Y; Mukherjee R; Haldar J
Nanoscale; 2024 Jun; 16(23):11109-11125. PubMed ID: 38787647
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of organo-selenium-incorporated urinary catheter tubing for in vitro growth inhibition of E. coli, K. pneumoniae, P. aeruginosa, and H. influenzae.
Jacobo U; Vopni R; Tran P; Patel S; Jain S; de Riese CS; Reid TW; de Riese WTW
Int Urol Nephrol; 2023 Mar; 55(3):503-510. PubMed ID: 36462116
[TBL] [Abstract][Full Text] [Related]
25. Improved antibiotic-impregnated catheters with extended-spectrum activity against resistant bacteria and fungi.
Raad I; Mohamed JA; Reitzel RA; Jiang Y; Raad S; Al Shuaibi M; Chaftari AM; Hachem RY
Antimicrob Agents Chemother; 2012 Feb; 56(2):935-41. PubMed ID: 22123686
[TBL] [Abstract][Full Text] [Related]
26. Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.
Shimizu T; Harada K
Microbiol Immunol; 2017 Jan; 61(1):17-22. PubMed ID: 28042660
[TBL] [Abstract][Full Text] [Related]
27. In vitro activities of N-acetyl cysteine and levofloxacin as a catheter lock therapy against catheter-associated infections.
Mansouri MD; Ramanthan V; Mansouri DL; Hull RA
J Appl Microbiol; 2022 May; 132(5):3915-3924. PubMed ID: 35157342
[TBL] [Abstract][Full Text] [Related]
28. Catheter-associated urinary tract infections: impact of catheter materials on their management.
Kumon H; Hashimoto H; Nishimura M; Monden K; Ono N
Int J Antimicrob Agents; 2001 Apr; 17(4):311-6. PubMed ID: 11295414
[TBL] [Abstract][Full Text] [Related]
29. Pathogen incidence and antibiotic resistance patterns of catheter-associated urinary tract infection in children.
Bi XC; Zhang B; Ye YK; He HC; Han ZD; Dai QS; Liang YX; Zeng GH; Wang YS; Chen QB; Zhong WD
J Chemother; 2009 Dec; 21(6):661-5. PubMed ID: 20071290
[TBL] [Abstract][Full Text] [Related]
30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
[TBL] [Abstract][Full Text] [Related]
32. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms.
Soboh F; Khoury AE; Zamboni AC; Davidson D; Mittelman MW
Antimicrob Agents Chemother; 1995 Jun; 39(6):1281-6. PubMed ID: 7574516
[TBL] [Abstract][Full Text] [Related]
33. Natural antioxidant pterostilbene as an effective antibiofilm agent, particularly for gram-positive cocci.
Vaňková E; Paldrychová M; Kašparová P; Lokočová K; Kodeš Z; Maťátková O; Kolouchová I; Masák J
World J Microbiol Biotechnol; 2020 Jul; 36(7):101. PubMed ID: 32613312
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model.
Gaonkar TA; Sampath LA; Modak SM
Infect Control Hosp Epidemiol; 2003 Jul; 24(7):506-13. PubMed ID: 12887239
[TBL] [Abstract][Full Text] [Related]
35. Use of Pistacia lentiscus mastic for sustained-release system of chlorocresol and benzoic acid for in vitro prevention of bacterial colonization of silicon urinary catheter.
Goda RM; Shohayeb MM
Lett Appl Microbiol; 2021 Nov; 73(5):599-606. PubMed ID: 34310728
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
Rahuman HBH; Dhandapani R; Palanivel V; Thangavelu S; Paramasivam R; Muthupandian S
PLoS One; 2021; 16(9):e0256748. PubMed ID: 34473763
[TBL] [Abstract][Full Text] [Related]
37. Method for studying development of colonization and infection of dialysis catheters.
Khaled GH; Finkelstein FO; Carey HB; Wardlaw SC; Kliger AS; Edberg SC
Adv Perit Dial; 2001; 17():163-71. PubMed ID: 11510268
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.
Akhter T; Baqai R; Aziz M
Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876
[TBL] [Abstract][Full Text] [Related]
39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Fujime M; Fujita K; Hirose T; Matsukawa M; Takahashi S; Kunishima Y; Igari J; Ogihara M; Ishibashi K; Oguri T; Shigeta S; Yamaguchi K; Matsumoto T; Kashitani F; Yoshida H; Imafuku Y; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Kitamura M; Takano Y; Matsuoka Y; Matsuda S; Sato S; Furuhama T; Kumon H; Monden K; Aoki S; Mochida C; Hirakata Y; Kohno S; Miyazaki Y; Tomono K
Jpn J Antibiot; 2002 Aug; 55(4):370-98. PubMed ID: 12378869
[TBL] [Abstract][Full Text] [Related]
40. Biofilm prevention of gram-negative bacterial pathogens involved in periprosthetic infection by antibiotic-loaded calcium sulfate beads in vitro.
Howlin RP; Winnard C; Frapwell CJ; Webb JS; Cooper JJ; Aiken SS; Stoodley P
Biomed Mater; 2016 Dec; 12(1):015002. PubMed ID: 27910828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
